Cardiac treatment
Pro Research Analysisby 
Searched over 200M research papers for "cardiac treatment"
Consensus Meter
Advances in Cardiac Treatment: A Comprehensive Overview
Psychological Treatment for Cardiac Patients
Impact on Mortality and Gender Differences
Psychological treatments (PTs) for cardiac patients have shown varying results in terms of effectiveness. A meta-analysis of 43 randomized controlled trials revealed that PT combined with usual care significantly reduced all-cause mortality within two years (OR 0.72) compared to usual care alone. However, this benefit diminished over longer follow-up periods (OR 0.89). Notably, the mortality benefits were significant only for men (OR 0.73), with no observed benefits for women (OR 1.01). The timing of PT initiation also played a crucial role, with treatments starting at least two months post-cardiac event showing greater mortality benefits (OR 0.28) compared to those initiated immediately after the event (OR 0.87).
Massage Therapy Post-Cardiac Surgery
Reduction in Pain, Anxiety, and Muscular Tension
Massage therapy has been found to significantly reduce pain, anxiety, and muscular tension in patients following cardiac surgery. A randomized trial involving 152 patients demonstrated that massage therapy led to greater reductions in pain (P = .001), anxiety (P < .0001), and muscular tension (P = .002), along with increased relaxation (P < .0001) and patient satisfaction (P = .016) compared to rest time. These benefits were observed without significant changes in heart rate, respiratory rate, or blood pressure.
Cell-Based Therapy for Myocardial Infarction
Promising Results and Future Directions
Cell-based therapy is emerging as a promising treatment for myocardial infarction (MI). Clinical studies have shown that therapies using adult bone marrow-derived cells can reduce infarct size and improve cardiac function by forming new blood vessels and providing proangiogenic and antiapoptotic factors . Despite these promising results, several questions remain, such as identifying the optimal cell type, delivery method, and timing for therapy. Additionally, while initial trials have not raised major safety concerns, potential side effects need careful monitoring.
Treatment of Cardiac Irregularities
Auricular Fibrillation and Extrasystoles
Auricular fibrillation is a common and serious cardiac irregularity, often accompanying cardiac failure. Effective treatment of these irregularities is crucial as they significantly impact the heart's pumping mechanism. Various methods, including medication and mechanical interventions, have been shown to manage these conditions effectively.
Innovations in Cardiac Disease Management
Drug Treatments and Technological Advances
Recent advancements in drug treatments, interventions, and diagnostic technologies have transformed cardiac disease management. For instance, beta-blockers have been demoted from first-line to third-line treatment for arterial hypertension, and coronary revascularizations are now predominantly performed by interventional cardiologists using coronary stents. New drugs like ivabradine and sacubitril/valsartan, along with cardiac resynchronization therapy, are recommended for heart failure patients with an ejection fraction below 35%. Additionally, monitoring for myocardial injury in non-cardiac surgery using troponin assays is becoming increasingly justified.
Regenerative Medicine for Ischemic Heart Disease
Stem Cell Therapy and Tissue Engineering
Regenerative medicine, particularly stem cell therapy, offers a novel approach to treating ischemic heart disease. Mesenchymal stem cells, which can be easily obtained and expanded, have shown potential in regenerating infarcted myocardium and improving cardiac function . Despite the promising benefits reported in clinical trials, the exact mechanisms of action remain unclear, necessitating further research. Cardiac tissue engineering, involving cells, scaffolds, and cytokines, also holds promise for myocardial regeneration and the prevention of heart failure post-MI.
Conclusion
The landscape of cardiac treatment is rapidly evolving with significant advancements in psychological therapies, massage therapy, cell-based treatments, and regenerative medicine. These innovations offer new hope for improving patient outcomes and managing cardiac diseases more effectively. However, ongoing research is essential to address the remaining uncertainties and optimize these therapies for broader clinical application.
Sources and full results
Most relevant research papers on this topic